Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Non-cash Items (2019 - 2025)

Cyclerion Therapeutics (CYCN) has disclosed Non-cash Items for 6 consecutive years, with $258558.0 as the latest value for Q4 2024.

  • For Q4 2024, Non-cash Items changed N/A year-over-year to $258558.0; the TTM value through Dec 2024 reached $258558.0, changed N/A, while the annual FY2024 figure was $258558.0, N/A changed from the prior year.
  • Non-cash Items hit $258558.0 in Q4 2024 for Cyclerion Therapeutics, up from $250429.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $4.6 million in Q1 2022 and bottomed at $1200.0 in Q2 2023.
  • Average Non-cash Items over 5 years is $576125.8, with a median of $200000.0 recorded in 2021.
  • Year-over-year, Non-cash Items crashed 98.8% in 2023 and then surged 20769.08% in 2024.
  • Cyclerion Therapeutics' Non-cash Items stood at $1.2 million in 2020, then tumbled by 83.02% to $200000.0 in 2021, then plummeted by 90.0% to $20000.0 in 2022, then skyrocketed by 1214.84% to $262967.0 in 2023, then fell by 1.68% to $258558.0 in 2024.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $258558.0, $250429.0, and $262967.0 for Q4 2024, Q2 2024, and Q3 2023 respectively.